Cumberland Pharmaceuticals (CPIX) Total Current Liabilities (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Total Current Liabilities across 17 years of filings, most recently posting $34.5 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $34.5 million, up 35.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $34.5 million (up 35.14% YoY), and the FY2025 annual result was $36.7 million, up 16.2% from the prior year.
• Total Current Liabilities came in at $34.5 million for Q1 2026 at Cumberland Pharmaceuticals, down from $36.7 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $36.7 million in Q4 2025 to a low of $24.0 million in Q2 2025.
• The 5-year median for Total Current Liabilities is $26.4 million (2024), against an average of $27.6 million.
• Across the five-year window, Total Current Liabilities soared 48.24% in 2022 and declined 21.8% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Total Current Liabilities stood at $28.6 million in 2022, then decreased by 2.09% to $28.0 million in 2023, then grew by 13.01% to $31.6 million in 2024, then advanced by 16.2% to $36.7 million in 2025, then dropped by 6.14% to $34.5 million in 2026.
• The last three Total Current Liabilities figures came in at $34.5 million (Q1 2026), $36.7 million (Q4 2025), and $24.3 million (Q3 2025), per Business Quant data.